[Form 4] Standex International Corporation Insider Trading Activity

Rhea-AI Filing Summary

Standex International Corporation (SXI) director Robin J. Davenport reported a small acquisition of common stock on 08/21/2025 under the company’s Dividend Reinvestment Plan (DRIP). The Form 4 shows an acquisition code J(1) for 1.782 shares at a reported price of $201.538 per share, resulting in 4,059.089 shares beneficially owned following the transaction.

The filing indicates the form was filed by one reporting person and lists Davenport’s relationship to the issuer as a director. The signature block shows the form was signed by Alan J. Glass on 08/25/2025. The filer states the purchase was made pursuant to the company’s DRIP; no other transactions or derivative positions are reported.

Insights

Financial Analyst

TL;DR: Director participation in DRIP slightly increases insider shareholding, no material change to ownership stake.

The reported acquisition of 1.782 shares at $201.538 under the Dividend Reinvestment Plan is routine and small relative to typical institutional holdings. The post-transaction beneficial ownership of 4,059.089 shares reflects the director’s ongoing participation but does not indicate a material shift in control or a sizable new exposure to the company. There are no derivative transactions or dispositions reported. For investors, this is a routine insider activity disclosure rather than a signal of strategic change.

Corporate Governance Expert

TL;DR: Routine disclosure shows compliance with Section 16; DRIP acquisition is customary for directors.

The Form 4 properly discloses a DRIP-based acquisition, the reporting person’s role as a director, and the updated beneficial ownership. The use of code J(1) and explicit explanation that the shares were acquired via the company’s Dividend Reinvestment Plan aligns with standard reporting practices. There are no indications of unusual timing, related-party transactions, or simultaneous derivative activity that would raise governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davenport Robin J

(Last) (First) (Middle)

STANDEX INTERNATIONAL CORPORATION

23 KEEWAYDIN DRIVE, SUITE 300

(Street)

SALEM NH 03079

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/21/2025		J(1)		1.782	A	$201.538	4,059.089	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents acquisition of stock pursuant to the Company's Dividend Reinvestment Plan.

	/s/ Alan J. Glass	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Standex (SXI) director Robin J. Davenport report on Form 4?

The Form 4 reports an acquisition of 1.782 shares of Standex common stock on 08/21/2025 under the company’s Dividend Reinvestment Plan (DRIP).

How many Standex (SXI) shares does Robin J. Davenport beneficially own after the transaction?

The filing shows 4,059.089 shares beneficially owned following the reported transaction.

What was the reported price per share for the DRIP purchase on the Form 4?

The reported price is $201.538 per share for the acquisition disclosed on the Form 4.

Was the Form 4 filed by multiple reporting persons or a single person?

The filing indicates a single reporting person: the box for Form filed by One Reporting Person is checked.

What is the reporting person’s relationship to Standex (SXI)?

The Form 4 indicates the reporting person, Robin J. Davenport, is a director of Standex International Corporation.